Q3 2023 13F Holders as of 9/30/2023
-
Type / Class
-
Equity / Common Stock, $0.001 par value per share
-
Shares outstanding
-
53.6M
-
Number of holders
-
54
-
Total 13F shares, excl. options
-
20.3M
-
Shares change
-
+14.9M
-
Total reported value, excl. options
-
$599M
-
Value change
-
+$451M
-
Number of buys
-
41
-
Number of sells
-
-12
-
Price
-
$29.51
Significant Holders of SOLENO THERAPEUTICS INC - Common Stock, $0.001 par value per share (SLNO) as of Q3 2023
58 filings reported holding SLNO - SOLENO THERAPEUTICS INC - Common Stock, $0.001 par value per share as of Q3 2023.
SOLENO THERAPEUTICS INC - Common Stock, $0.001 par value per share (SLNO) has 54 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 20.3M shares
of 53.6M outstanding shares and own 37.88% of the company stock.
Largest 10 shareholders include Vivo Capital, LLC (3.2M shares), PERCEPTIVE ADVISORS LLC (3.07M shares), Carlyle Group Inc. (2.29M shares), JANUS HENDERSON GROUP PLC (2.2M shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (1.33M shares), RA CAPITAL MANAGEMENT, L.P. (1.24M shares), Fairmount Funds Management LLC (1.14M shares), COMMODORE CAPITAL LP (888K shares), Ikarian Capital, LLC (537K shares), and Frazier Life Sciences Management, L.P. (465K shares).
This table shows the top 54 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.